Banque Cantonale Vaudoise Buys 1,252 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Banque Cantonale Vaudoise raised its holdings in Aspen Aerogels, Inc. (NYSE:ASPN) by 37.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,593 shares of the construction company’s stock after acquiring an additional 1,252 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Aspen Aerogels were worth $81,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Thompson Davis & CO. Inc. boosted its stake in Aspen Aerogels by 14.7% in the fourth quarter. Thompson Davis & CO. Inc. now owns 24,150 shares of the construction company’s stock valued at $381,000 after acquiring an additional 3,100 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Aspen Aerogels by 38.5% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock valued at $205,000 after acquiring an additional 3,607 shares during the last quarter. Bouvel Investment Partners LLC boosted its stake in Aspen Aerogels by 4.3% in the fourth quarter. Bouvel Investment Partners LLC now owns 94,318 shares of the construction company’s stock valued at $1,488,000 after acquiring an additional 3,929 shares during the last quarter. Zevenbergen Capital Investments LLC boosted its stake in Aspen Aerogels by 2.4% in the fourth quarter. Zevenbergen Capital Investments LLC now owns 280,802 shares of the construction company’s stock valued at $4,431,000 after acquiring an additional 6,575 shares during the last quarter. Finally, McAdam LLC bought a new position in Aspen Aerogels in the fourth quarter valued at approximately $191,000. 97.64% of the stock is owned by institutional investors.

Insider Buying and Selling at Aspen Aerogels

In other Aspen Aerogels news, SVP Corby C. Whitaker sold 55,159 shares of Aspen Aerogels stock in a transaction on Monday, May 6th. The shares were sold at an average price of $25.01, for a total value of $1,379,526.59. Following the sale, the senior vice president now directly owns 131,533 shares in the company, valued at approximately $3,289,640.33. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Aspen Aerogels news, SVP Corby C. Whitaker sold 55,159 shares of Aspen Aerogels stock in a transaction on Monday, May 6th. The shares were sold at an average price of $25.01, for a total value of $1,379,526.59. Following the sale, the senior vice president now directly owns 131,533 shares in the company, valued at approximately $3,289,640.33. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Keith L. Schilling sold 20,000 shares of Aspen Aerogels stock in a transaction on Monday, May 13th. The shares were sold at an average price of $26.84, for a total transaction of $536,800.00. Following the completion of the sale, the senior vice president now owns 28,792 shares in the company, valued at $772,777.28. The disclosure for this sale can be found here. In the last three months, insiders have sold 3,832,103 shares of company stock worth $91,679,369. Insiders own 4.30% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have issued reports on ASPN. TheStreet raised shares of Aspen Aerogels from a “d+” rating to a “c-” rating in a research note on Wednesday, March 6th. Piper Sandler increased their target price on shares of Aspen Aerogels from $30.00 to $36.00 and gave the stock an “overweight” rating in a report on Wednesday, May 29th. Canaccord Genuity Group increased their target price on shares of Aspen Aerogels from $18.00 to $28.00 and gave the stock a “buy” rating in a report on Friday, May 3rd. Craig Hallum increased their target price on shares of Aspen Aerogels from $33.00 to $38.00 and gave the stock a “buy” rating in a report on Friday, June 14th. Finally, B. Riley increased their target price on shares of Aspen Aerogels from $24.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, May 3rd. One research analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, Aspen Aerogels presently has a consensus rating of “Moderate Buy” and an average target price of $30.75.

Aspen Aerogels Trading Down 2.1 %

Shares of NYSE:ASPN opened at $24.74 on Tuesday. Aspen Aerogels, Inc. has a 12 month low of $5.32 and a 12 month high of $31.74. The company has a quick ratio of 3.29, a current ratio of 4.01 and a debt-to-equity ratio of 0.24. The company’s fifty day simple moving average is $25.15 and its 200 day simple moving average is $18.55. The firm has a market cap of $1.88 billion, a price-to-earnings ratio of -56.23 and a beta of 2.29.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Wednesday, May 1st. The construction company reported $0.01 EPS for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.14. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. The business had revenue of $94.50 million for the quarter, compared to analyst estimates of $73.04 million. As a group, research analysts forecast that Aspen Aerogels, Inc. will post 0.16 EPS for the current fiscal year.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.